scispace - formally typeset
A

Andrés R. Alcántara

Researcher at Complutense University of Madrid

Publications -  133
Citations -  4272

Andrés R. Alcántara is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Lipase & Catalysis. The author has an hindex of 28, co-authored 122 publications receiving 3205 citations. Previous affiliations of Andrés R. Alcántara include University of Córdoba (Spain).

Papers
More filters
Journal ArticleDOI

2‐Methyltetrahydrofuran (2‐MeTHF): A Biomass‐Derived Solvent with Broad Application in Organic Chemistry

TL;DR: The properties of 2-MeTHF, the state-of-the-art of its use in synthesis, and several outstanding examples of its application from both industry and academia are described.
Journal ArticleDOI

Immobilization of lipases on hydrophobic supports: immobilization mechanism, advantages, problems, and solutions.

TL;DR: These immobilized lipases may be subject to unfolding and refolding strategies to reactivate inactivated enzymes, and these biocatalysts have been used in new strategies for enzyme coimmobilization, where the most stable enzyme could be reutilized after desorption of the least stable one after its inactivation.
Journal ArticleDOI

Understanding Candida rugosa lipases: an overview.

TL;DR: In the present paper the recent developments published in the CRL field are overviewed, focusing on comparison of structural and biochemical data among isoenzymes (Lip1-Lip5), and their influence in the biocatalytical performance.
Journal ArticleDOI

Biocatalytic Strategies for the Asymmetric Synthesis of α-Hydroxy Ketones

TL;DR: The field represents an illustrative example of how biocatalysis can assist practical synthetic processes, and how problems derived from the integration of natural tools in synthetic pathways can be efficiently tackled to afford high yields and enantioselectivities.
Journal ArticleDOI

Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs

TL;DR: This review is focused on describing several industrial processes based on the use of hydrolases and oxido-reductases for obtaining chiral compounds useful for the pharmaceutical industry.